WKN: | A40ZZU |
ISIN: | NL0015002CX3 |
Land: | Niederlande |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Qiagen-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 26. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 1999 | 6,81 | 18,71 | 174,74% |
2 | 2000 | 18,71 | 38,63 | 106,47% |
3 | 1997 | 2,48 | 5,01 | 102,02% |
4 | 2003 | 4,99 | 9,72 | 94,79% |
5 | 2020 | 30,37 | 42,94 | 41,39% |
6 | 1998 | 5,01 | 6,81 | 35,93% |
7 | 2015 | 19,19 | 25,25 | 31,58% |
8 | 2012 | 10,68 | 13,69 | 28,18% |
9 | 2007 | 11,62 | 14,80 | 27,37% |
10 | 2009 | 12,27 | 15,58 | 26,98% |
11 | 2013 | 13,69 | 16,96 | 23,89% |
12 | 2005 | 8,08 | 9,91 | 22,65% |
13 | 2006 | 9,91 | 11,62 | 17,26% |
14 | 2021 | 42,94 | 49,25 | 14,69% |
15 | 2014 | 16,96 | 19,19 | 13,15% |
16 | 2018 | 26,13 | 29,44 | 12,67% |
17 | 2024 | 39,31 | 42,96 | 9,29% |
18 | 2016 | 25,25 | 26,75 | 5,94% |
19 | 2019 | 29,44 | 30,37 | 3,16% |
20 | 2017 | 26,75 | 26,13 | -2,32% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 21,11 | 4,99 | -76,36% |
2 | 2001 | 38,63 | 21,11 | -45,35% |
3 | 2011 | 14,72 | 10,68 | -27,45% |
4 | 2008 | 14,80 | 12,27 | -17,09% |
5 | 2004 | 9,72 | 8,08 | -16,87% |
6 | 2023 | 46,98 | 39,31 | -16,33% |
7 | 2025 | 42,96 | 37,97 | -11,62% |
8 | 2010 | 15,58 | 14,72 | -5,52% |
9 | 2022 | 49,25 | 46,98 | -4,61% |
10 | 2017 | 26,75 | 26,13 | -2,32% |
11 | 2019 | 29,44 | 30,37 | 3,16% |
12 | 2016 | 25,25 | 26,75 | 5,94% |
13 | 2024 | 39,31 | 42,96 | 9,29% |
14 | 2018 | 26,13 | 29,44 | 12,67% |
15 | 2014 | 16,96 | 19,19 | 13,15% |
16 | 2021 | 42,94 | 49,25 | 14,69% |
17 | 2006 | 9,91 | 11,62 | 17,26% |
18 | 2005 | 8,08 | 9,91 | 22,65% |
19 | 2013 | 13,69 | 16,96 | 23,89% |
20 | 2009 | 12,27 | 15,58 | 26,98% |